发明名称 Controlled release dosage form
摘要 The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
申请公布号 US9585843(B2) 申请公布日期 2017.03.07
申请号 US201615132972 申请日期 2016.04.19
申请人 Osmotica Kereskedelmi es Szoloaltato Kft 发明人 Meyer Glenn A.;Franco Cristian R.;Fischbein Gustavo A.;Aguilar Alejandro A.;Wright Claude E.
分类号 A61K9/28;A61K9/00;A61K31/197;A61K9/20;A61K31/325;A61K9/14 主分类号 A61K9/28
代理机构 Innovar, L.L.C. 代理人 Matos Rick;Innovar, L.L.C.
主权项 1. A controlled release oral dosage form comprising: a) a core comprising at least one GABAB receptor agonist and at least two water-swellable excipients; and b) a semipermeable membrane surrounding the core, said membrane comprising at least two film-forming cellulose esters and at least one preformed passageway; wherein the at least one GABAB receptor agonist is (R)-baclofen (ARBAC); and following oral administration of said dosage form, the dosage form releases a majority of ARBAC downstream of the stomach and upstream of the colon.
地址 Budapest HU